AUTL
USDAutolus Therapeutics plc American Depositary Share
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$1.520
Máximo
$1.535
Mínimo
$1.400
Volume
2.28M
Fundamentos da empresa
Capitalização de mercado
375.3M
Setor
Biotecnologia
País
United Kingdom
Estatísticas de negociação
Volume médio
3.73M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target
Needham analyst Gil Blum reiterates Autolus Therapeutics with a Buy and maintains $10 price target.
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2025
LONDON and GAITHERSBURG, Md., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation
Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology Convergence 2025
Data from the Phase 1 CARLYSLE study in severe refractory systemic lupus erythematosus (srSLE) suggests obe-cel is well tolerated with no ICANS or high-grade CRS; 50 million cell dose selected for Phase 2 pivotal
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.